The VERIFY Study: An Observational Study Called VERIFY to Learn More About the Use of Vericiguat in People With Chronic Heart Failure With Reduced Ejection Fraction

CompletedOBSERVATIONAL
Enrollment

1,391

Participants

Timeline

Start Date

July 11, 2023

Primary Completion Date

October 8, 2024

Study Completion Date

October 8, 2024

Conditions
Chronic Heart Failure With Reduced Ejection Fraction
Trial Locations (1)

13342

Bayer, Berlin

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY